“…Another limitation was the lack of IHPS data for the entire study period from three of the 11 participating surveillance programs. Also, we lacked data on selected infant and parental characteristics from some surveillance programs, as well as data on maternal behavioral and medication exposures that may contribute to IHPS, including maternal cigarette smoking during pregnancy (Krogh et al, ; Leite, Albieri, Kjaer, & Jensen, ; Markel et al, ; Sorensen, Norgard, Pedersen, Larsen, & Johnsen, ; Svenningsson et al, ) and maternal use of medications during pregnancy, such as any macrolide (Ludvigsson, Lundholm, Ortqvist, & Almqvist, ; Lund et al, ), erythromycin (Cooper et al, ; Louik, Werler, & Mitchell, ), azithromycin (Eberly, Eide, Thompson, & Nylund, ), decongestants (Yau, Mitchell, Lin, Werler, & Hernandez‐Diaz, ), and bendectin (Eskenazi & Bracken, ). Nonetheless, more than 99% of data were available for each selected infant or parental characteristic, except maternal race/ethnicity, parity, and paternal race/ethnicity, for which only 80%, 75%, and 67% of data, respectively, were available.…”